Accent Capital Management
GSK icon

Accent Capital Management’s GSK GSK Stock Holding History

Accent Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-781
Closed -$41.3K – 331
2026
Q2 		$41.3K Hold
781
– – 0.02% 117
2026
Q1 		$43.1K Buy
+781
New +$42.3K 0.02% 114
2025
Q3 		– Sell
-120
Closed -$4.66K – 397
2025
Q2 		$4.66K Hold
120
– – ﹤0.01% 337
2025
Q1 		$5.02K Sell
120
-800
-87% -$29.3K ﹤0.01% 255
2024
Q4 		$31.5K Hold
920
– – 0.02% 93
2024
Q3 		$38K Hold
920
– – 0.02% 106
2024
Q2 		$35.4K Hold
920
– – 0.02% 108
2024
Q1 		$39.8K Hold
920
– – 0.03% 86
2023
Q4 		$34.1K Buy
+920
New +$33K 0.03% 117

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Accent Capital Management's GSK Position: Q3 2026 in Review

Accent Capital Management sold out of GSK (GSK) in Q3 2026, closing a stake of 781 shares — an estimated $41.3K sold.

Accent Capital Management first reported a position in GSK in Q4 2023 and held it in 9 quarters. The position peaked at $43.1K in Q1 2026. 766 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Accent Capital Management reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Accent Capital Management sold 781 GSK shares in Q3 2026, an estimated $41.3K.
  • Accent Capital Management first reported a position in GSK in Q4 2023 and held it in 9 quarters.
  • Accent Capital Management's GSK position peaked at $43.1K in Q1 2026.
  • 766 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Accent Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.